Thrive Bioscience Launches Innovative Live Cell Imaging Software for Improved Cell-Based Research

Thrive Bioscience Inc., a provider of innovative automated live cell imaging instruments and software, debuted its CellAssist Software Release 5.0, a new i...

December 20, 2023 | Wednesday | News
Charles River, Vertex Pharma Achieve Key Milestone in Cell Therapy Manufacturing Partnership

Charles River Laboratories International, Inc.  announced an important milestone in their strategic collaboration to manufacture CASGEVY™ (...

December 19, 2023 | Tuesday | News
CHMP Greenlights Biogen's SKYCLARYS® for Rare Neurodegenerative Disease

Friedreich’s ataxia is a genetic, debilitating and life-shortening neuromuscular disease1 Milestone highlights Biogen’s growing portfolio in...

December 18, 2023 | Monday | News
Parse Biosciences Secures $50M for Global Growth

Parse Biosciences, a leading provider of easily accessible and scalable solutions for single-cell sequencing, announced today that the company has raised $...

December 18, 2023 | Monday | News
Atomic AI Optimizes RNA Therapeutic Development with Chemical Mapping Data

Atomic AI’s ATOM-1 large language model (LLM) demonstrates state-of-the-art accuracy for predicting RNA structure and function Technology can be exp...

December 18, 2023 | Monday | News
OmniAb Unveils Latest Scientific Data on OmnidAb™ Platform at 2023 Antibody Engineering Conference

OmniAb, Inc.  announces the presentation of new scientific data on its OmnidAb™ platform, the industry’s first and only transgenic chicken...

December 15, 2023 | Friday | News
Roche Acquires Telavant, Gains Rights to Innovative Antibody (RVT-3101) for Inflammatory Bowel Disease

Roivant (Nasdaq: ROIV) announced  the completion of the previously announced acquisition by Roche (SIX: RO, ROG; OTCQX: RHHBY) of Telavant, for an upf...

December 15, 2023 | Friday | News
Novozymes and Chr. Hansen Unveil Unified Identity: Novonesis, Marking a Powerful Synergy in the Biotech Industry

Novozymes and Chr. Hansen announced their future name ‘Novonesis’. The name reflects the beginning of an era of biosolutions where Novonesis wi...

December 13, 2023 | Wednesday | News
AstraZeneca to Acquire Icosavax, Including Promising Phase II RSV and hMPV Combination Vaccine

AstraZeneca has entered into a definitive agreement to acquire Icosavax, Inc. (NASDAQ: ICVX), a US-based clinical-stage biopharmaceutical company focused o...

December 12, 2023 | Tuesday | News
Charles River Finalizes Agreement with CELLphenomics

CELLphenomics’ PD3D® tumor model platform will expand Charles River’s portfolio of 3D in vitro testing services Charles Rive...

December 12, 2023 | Tuesday | News
Merck Partners with Acceleration Consortium for AI-Driven Experimentation Open Source

Bayesian optimization engine that already powers dozens of use cases at Merck now open sourced to foster adoption Close partnership to enable the self-d...

December 11, 2023 | Monday | News
Bayer and Salus Optima Partner on AI-Enabled Healthy Aging Journey

With personalized, data-driven recommendations delivered through mobile applications, the partners provide consumers with tips, recommendations, and motiva...

December 08, 2023 | Friday | News
Sanofi's Pipeline Transformation for Immunology Leadership Through Record Potential Blockbusters

Details strong pipeline including Sanofi’s record 12 blockbuster opportunities under clinical evaluation: 9 innovative medicines and vaccines with ...

December 07, 2023 | Thursday | News
Global CDMO, Vetter, Advances Sustainability with Science Based Targets Initiative (SBTi) Membership.

As a result, Vetter has committed to the 1.5 degrees of global warming target. To this end, the CDMO has presented a sustainability strategy with concrete ...

December 06, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close